MTCM
FMTX

Mint Tower Capital Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Mint Tower Capital Management’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-8,200
Closed -$164K – 607
2022
Q3 		$164K Buy
+8,200
New +$108K 0.01% 394

Mint Tower Capital Management's FMTX Position: Q4 2022 in Review

Mint Tower Capital Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 8,200 shares — an estimated $164K sold.

Mint Tower Capital Management first reported a position in FMTX in Q3 2022 and held it in 1 quarter. The position peaked at $164K in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Mint Tower Capital Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Mint Tower Capital Management sold 8,200 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $164K.
  • Mint Tower Capital Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Mint Tower Capital Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $164K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Mint Tower Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.